So they have $23 million at the end of last quarter, add into that the $39 million they have received from BI. That puts them to $62 million in the bank. That would be the market cap at 20c.
They have agreements if all goes well in the trials and applications for the drug to receive another $280 million. If you were to introduce that into it, the market cap would be $1.08 just on those cash received. Not to mention they are in agreements with Chiesi over Bronchitol. Which will continue to add to the funds.
PXS Price at posting:
16.5¢ Sentiment: Buy Disclosure: Held
